Literature DB >> 12957397

The humoral response to in vitro generated parasite antigens is enhanced by the removal of a defined media component prior to immunization.

Christopher G Earnhart1, Stephen L Kaattari.   

Abstract

Concentrated culture supernatants containing the extracellular products (ECP) of the protozoan oyster parasite Perkinsus marinus were used to immunize mice. This preparation, produced by ultrafiltration, was found to be both poorly immunogenic and toxic to experimental animals. The possibility that these effects were due to toxic parasite products and/or medium constituents was examined. Co-administration of this material with highly immunogenic oyster hemolymph caused a substantive suppression of the specific antibody response to hemolymph, as well as a decrease in the number of epitopes recognized. Potential protein/protease toxin-mediated causes of the immunosuppression were addressed by heat denaturation and proteolytic inhibition of the concentrate; neither substantially enhanced immunogenicity. Analysis of media constituents revealed that the known immunomodulatory surfactant, Pluronic F-68 (PF68), used in the defined lipid concentrate supplement, was capable of eliciting significant immunosuppression. Although isolated protein antigens from P. marinus ECP remain highly immunosuppressive, separation of the protein antigens from the PF68 has enabled production of polyclonal antisera with a broader recognition of antigens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12957397     DOI: 10.1016/s0022-1759(03)00227-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  1 in total

1.  Supplementation of Perkinsus marinus cultures with host plasma or tissue homogenate enhances their infectivity.

Authors:  Christopher G Earnhart; Mary Ann Vogelbein; Gwynne D Brown; Kimberly S Reece; Stephen L Kaattari
Journal:  Appl Environ Microbiol       Date:  2004-01       Impact factor: 4.792

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.